[HTML][HTML] The neutrophil-to-lymphocyte ratio: a narrative review

SS Faria, PC Fernandes Jr, MJB Silva… - …, 2016 - ncbi.nlm.nih.gov
Cellular-mediated inflammatory response, lymphocytes, neutrophils, and monocytes are
increasingly being recognised as having an important role in tumorigenesis and …

Routine clinical markers of the magnitude of the systemic inflammatory response after elective operation: a systematic review

DG Watt, PG Horgan, DC McMillan - Surgery, 2015 - Elsevier
Background Operative injury to the body from all procedures causes a stereotypical cascade
of neuroendocrine, cytokine, myeloid, and acute phase responses. This response has been …

[HTML][HTML] Influence of perioperative anaesthetic and analgesic interventions on oncological outcomes: a narrative review

T Wall, A Sherwin, D Ma, DJ Buggy - British journal of anaesthesia, 2019 - Elsevier
Surgery is an important treatment modality for the majority of solid organ cancers.
Unfortunately, cancer recurrence following surgery of curative intent is common, and …

Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis

JL Ethier, D Desautels, A Templeton, PS Shah… - Breast Cancer …, 2017 - Springer
Background The presence of a high neutrophil-to-lymphocyte ratio (NLR) has been
associated with increased mortality in several malignancies. Here, we quantify the effect of …

Prognostic value of neutrophil‐to‐lymphocyte ratio and platelet‐to‐lymphocyte ratio for breast cancer patients: An updated meta‐analysis of 17079 individuals

W Guo, X Lu, Q Liu, T Zhang, P Li, W Qiao… - Cancer …, 2019 - Wiley Online Library
Aims This study aimed to evaluate the prognostic effect of neutrophil‐to‐lymphocyte ratio
(NLR) and platelet‐to‐lymphocyte ratio (PLR) for patients with breast cancer (BC). Methods …

[HTML][HTML] Repurposing drugs in oncology (ReDO)—Cimetidine as an anti-cancer agent

P Pantziarka, G Bouche, L Meheus… - …, 2014 - ncbi.nlm.nih.gov
Cimetidine, the first H 2 receptor antagonist in widespread clinical use, has anti-cancer
properties that have been elucidated in a broad range of pre-clinical and clinical studies for …

DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG

O Shriwas, M Priyadarshini, SK Samal, R Rath… - Apoptosis, 2020 - Springer
Platinum based drugs alone or in combination with 5FU and docetaxel are common regimen
chemotherapeutics for the treatment of advanced OSCC. Chemoresistance is one of the …

Neutrophil to lymphocyte ratio as prognostic and predictive factor in breast cancer patients: a systematic review

I Corbeau, W Jacot, S Guiu - Cancers, 2020 - mdpi.com
Inflammatory blood markers (IBM), such as the neutrophil to lymphocyte ratio (NLR), have
emerged as potential prognostic factors in various cancers, including breast cancer (BC) …

Perioperative anesthesia care and tumor progression

MW Sekandarzad, AAJ van Zundert, PB Lirk… - Anesthesia & …, 2017 - journals.lww.com
IMMUNE PATHOGENESIS The principal line of defense against cancer cell invasion and
metastasis is established via the host's innate and adaptive immune response. The key …

Multi-organ system for the evaluation of efficacy and off-target toxicity of anticancer therapeutics

CW McAleer, CJ Long, D Elbrecht… - Science translational …, 2019 - science.org
A pumpless, reconfigurable, multi-organ–on–a–chip system containing recirculating serum-
free medium can be used to predict preclinical on-target efficacy, metabolic conversion, and …